Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HHS Raises Profile In Drug Costs Discussion

This article was originally published in The Pink Sheet Daily

Executive Summary

On Nov. 20, HHS will host a day-long forum on pharmaceuticals, including a look at high-cost specialty drugs and innovative purchasing strategies.

You may also be interested in...

HHS Drug Cost Forum: Merck, Novartis To Represent Industry View

The two big pharmas are the only representatives of branded drug manufacturers scheduled to participate in the meeting. GPhA’s Chip Davis is on the agenda to represent the generic drug industry's point of view.

Time Is Now For Shaping CMS Drug Affordability, Innovation Policies – Slavitt

Acting Administrator Andy Slavitt explains CMS is in information-gathering mode as it considers ways of addressing accelerating drug costs in Medicare and Medicaid.

PhRMA Pushing For Policies To Facilitate Outcomes-Based Pricing

Industry group is promoting policy changes such as allowing broader communications with payers and a safe harbor for patient adherence programs that may help manufacturers and payers negotiate outcomes-based contracts for biopharma products.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts